- Home
- SMHI vs ADCT Comparison
SMHI vs ADCT Comparison
Compare SMHI & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMHI
- ADCT
- Stock Information
- Founded
- SMHI 1989
- ADCT 2011
- Country
- SMHI United States
- ADCT Switzerland
- Employees
- SMHI N/A
- ADCT N/A
- Industry
- SMHI Marine Transportation
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- SMHI Consumer Discretionary
- ADCT Health Care
- Exchange
- SMHI Nasdaq
- ADCT Nasdaq
- Market Cap
- SMHI 189.9M
- ADCT 224.3M
- IPO Year
- SMHI N/A
- ADCT 2020
- Fundamental
- Price
- SMHI $6.85
- ADCT $1.71
- Analyst Decision
- SMHI
- ADCT Strong Buy
- Analyst Count
- SMHI 0
- ADCT 5
- Target Price
- SMHI N/A
- ADCT $8.00
- AVG Volume (30 Days)
- SMHI 162.3K
- ADCT 709.5K
- Earning Date
- SMHI 02-27-2025
- ADCT 03-12-2025
- Dividend Yield
- SMHI N/A
- ADCT N/A
- EPS Growth
- SMHI N/A
- ADCT N/A
- EPS
- SMHI N/A
- ADCT N/A
- Revenue
- SMHI $274,636,000.00
- ADCT $70,717,000.00
- Revenue This Year
- SMHI $6.04
- ADCT $6.81
- Revenue Next Year
- SMHI $11.18
- ADCT $11.23
- P/E Ratio
- SMHI N/A
- ADCT N/A
- Revenue Growth
- SMHI 3.89
- ADCT N/A
- 52 Week Low
- SMHI $5.80
- ADCT $1.68
- 52 Week High
- SMHI $15.36
- ADCT $6.04
- Technical
- Relative Strength Index (RSI)
- SMHI 49.67
- ADCT 40.45
- Support Level
- SMHI $6.90
- ADCT $1.68
- Resistance Level
- SMHI $7.28
- ADCT $1.87
- Average True Range (ATR)
- SMHI 0.34
- ADCT 0.13
- MACD
- SMHI 0.04
- ADCT 0.00
- Stochastic Oscillator
- SMHI 37.25
- ADCT 8.65
About SMHI SEACOR Marine Holdings Inc.
Seacor Marine Holdings Inc provides world-wide marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations including wind farms; handle anchors and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico); Africa and Europe; Middle East and Asia and Latin America.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.